bioRxiv/medRxiv TRiP Review Activity

279 Reviews — eLife — Cancer Biology

Most recent first Previous |  Page 6: Articles 51-60  | Next

Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer
Li, S., Song, K., Sun, H., Tao, Y., Huang, A., Bhatia, V., Hanratty, B., Patel, R. A., Long, H. W., Morrissey, C., Haffner, M. C., Nelson, P. S., Graeber, T. G., Lee, J. K.
10.1101/2025.02.12.637904 — Posted: 2025-02-17 — Discussion: 2025-04-30  eLife
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling
Nakagawa, R., Beardsley, A., Durney, S., Hayward, M.-K., Subramanyam, V., Meyer, N. P., Wismer, H., Goodarzi, H., Weaver, V. M., Van de Mark, D., Goga, A.
10.1101/2024.09.26.615226 — Posted: 2024-09-28 — Discussion: 2025-04-25  eLife
Microenvironmental arginine restriction sensitizes pancreatic cancers to polyunsaturated fatty acids by suppression of lipid synthesis
Jonker, P. B., Sadullozoda, M., Cognet, G., Saab, J. J. A., Sokol, K. H., Wu, V. X., Kumari, D., Sheehan, C., Ozgurses, M. E., Agovino, D., Croley, G., Patel, S. A., Bock-Hughes, A., Macleod, K. F., Shah, H., Coloff, J. L., Lien, E. C., Muir, A.
10.1101/2025.03.10.642426 — Posted: 2025-03-13 — Discussion: 2025-04-23  eLife
A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer
Usman, S., Yeudall, W. A., Teh, M.-T., Ghaloum, F., Tummala, H., Waseem, A.
10.1101/2024.11.13.623301 — Posted: 2024-11-15 — Discussion: 2025-04-22  eLife
Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab resistant HER2 positive breast cancer
Hua, Y., Duan, N., Sun, C., Yang, F., Tian, M., Sun, Y., Zhao, S., Gong, J., Liu, Q., Huang, X., Liang, Y., Fu, Z., Li, W., Yin, Y.
10.1101/2024.11.12.623302 — Posted: 2024-11-15 — Discussion: 2025-04-22  eLife
DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma
Pal Singh, S., van den Beukel, M. D., van Deventer, S., Overdijk, M. B., Roukens, G., Santegoets, K. C. M., Breij, E. C. W., ter Beest, M., van Spriel, A. B.
10.1101/2025.02.24.639899 — Posted: 2025-02-28 — Discussion: 2025-04-22  eLife
RUNX2 Isoform II Protects Cancer Cells from Ferroptosis by Promoting PRDX2 Expression in Oral Squamous Cell Carcinoma
Huang, J., Jia, R., Guo, J.
10.1101/2024.05.17.594656 — Posted: 2024-05-18 — Discussion: 2025-04-17  eLife
Δ133p53 and Δ160p53 isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
Zhao, L., Punga, T., Sanyal, S.
10.1101/2024.07.23.604790 — Posted: 2024-07-24 — Discussion: 2025-04-17  eLife
VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300
Guo, S., Hu, X., Cotton, J. L., Ma, L., Li, Q., Cui, J., Wang, Y., Thakare, R. P., Tao, Z., Ip, T., Wu, X., Wang, J., Mao, J.
10.1101/2024.05.01.592016 — Posted: 2024-05-03 — Discussion: 2025-04-14  eLife
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer
Bhattacharya, A., Stutvoet, T. S., Perla, M., Loipfinger, S., Jalving, M., Reyners, A. K. L., Vermeer, P. D., Drapkin, R., de Bruyn, M., de Vries, E. G. E., de Jong, S., Fehrmann, R. S. N.
10.1101/2024.10.21.619015 — Posted: 2024-10-24 — Discussion: 2025-04-10  eLife

Evaluation Sources